EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty

Xinguang Wang, Zhencan Han iD, Guowei Zhang, Shantao Zhang, Zijian Li, Hua Tian iD

Clinical and Applied Thrombosis/Hemostasis · 2024

DOI: 10.1177/10760296241306749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2024. Verfasst von Xinguang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Hemostatics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Peking University Third Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study evaluated the safety and efficacy of SURGICEL® Powder–Absorbable Hemostatic Powder (SP) made from oxidized regenerated cellulose (ORC) in total knee arthroplasty (TKA). Ninety-one patients who underwent TKA at Peking University Third Hospital between January 2024 and July 2024 were retrospectively analyzed. Hemostatic effectiveness was evaluated by comparing perioperative blood loss, hemoglobin (Hb) levels, hematocrit (HCT), and transfusion rates. Clinical safety was assessed by comparing complication rates, operation time, visual analog scale (VAS) scores, and postoperative fever. Finally, 85 patients were included: 43 in the SP group (using SP) and 42 in the control group (not using SP). There were no significant differences in age, sex, height, weight, preoperative HCT, or Hb levels. The volume of perioperative blood loss within 3 days in the SP group was reduced by approximately 154 ml compared with that in the control group. The Hb and HCT levels in the SP group were higher on the first, second, and third days after surgery, and there were significant differences between the two groups in terms of repeated measurements of HCT and Hb levels within 3 days postoperatively. There were no statistically significant differences in the operation time, postoperative VAS scores, complications, transfusion rates, or postoperative fever. In conclusion, this study confirmed that SP can significantly reduce perioperative blood loss in TKA without negatively affecting clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, KneeHemostaticsHumansMaleFemaleRetrospective StudiesAgedMiddle AgedPowdersBlood Loss, SurgicalCellulose, Oxidized

Stichwörter der Autor:innen

TKAefficacyhemostasishemostatic powdersafetysurgicel

Substanzen

HemostaticsPowdersSurgicelCellulose, Oxidized

Autor:innen und Institutionen

  • Department of Orthopedics, Peking University Third Hospital, Beijing, China.
  • Department of Orthopedics, Muping District Traditional Chinese Medicine Hospital, Yantai City, China.

ORCID-Profile: Zhencan Han, Hua Tian

Förderung

  • Peking University Third Hospital

Zitieren

APA

Wang, X., Han, Z., Zhang, G., Zhang, S., Li, Z., & Tian, H. (2024). Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296241306749

Vancouver

Wang X, Han Z, Zhang G, Zhang S, Li Z, Tian H. Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty. Clinical and Applied Thrombosis/Hemostasis. 2024. doi:10.1177/10760296241306749

BibTeX
@article{Wang2024,
  author = {Wang, Xinguang and Han, Zhencan and Zhang, Guowei and Zhang, Shantao and Li, Zijian and Tian, Hua},
  title = {Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2024},
  doi = {10.1177/10760296241306749}
}
Kostenlos starten →